Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum
- 1 September 1991
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 28 (9), 1003-1009
- https://doi.org/10.1016/0161-5890(91)90186-n
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trialsMolecular and Biochemical Parasitology, 1989
- 1H‐nmr studies of synthetic polypeptide models of Plasmodium falciparum circumsporozoite protein tandemly repeated sequenceBiopolymers, 1989
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- In Vitro and in Vivo Results Suggesting That Anti-Sporozoite Antibodies Do Not Totally BlockPlasmodium falciparumSporozoite InfectivityNew England Journal of Medicine, 1986
- Effect of Antibodies to Recombinant and Synthetic Peptides on P. falciparum Sporozoites in VitroScience, 1986
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985
- Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.The Journal of Experimental Medicine, 1983
- Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.The Journal of Experimental Medicine, 1982
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975